Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 29, 2018Proceedings of the National Academy of SciencesOpen Access

OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation

View Full Paper
Ask AI
Bookmark
Share

Authors

CMCarlo MarchettiUniversity of Colorado Anschutz Medical CampusBSBenjamin J. SwartzwelterYale UniversityFGFabia GamboniUniversity of Colorado Anschutz Medical Campus

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Marchetti et al. (2018) studied this question.

synapsesocial.com/papers/69dff696b28b234044e9c0d3https://doi.org/10.1073/pnas.1716095115
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome2009 · 869 citations
  2. 2Activation of naïve CD4 T cells by anti-CD3 reveals an important role for Fyn in Lck-mediated signaling2004 · 57 citations
  3. 3The mitochondrial citrate carrier: a new player in inflammation2011 · 378 citations
  4. 4Inflammasome and IL-1β-Mediated Disorders2010 · 149 citations
  5. 5Clathrin complexes with the inhibitor kappa B kinase signalosome: imaging the interactome2014 · 5 citations